DE3043446C2 - - Google Patents

Info

Publication number
DE3043446C2
DE3043446C2 DE3043446A DE3043446A DE3043446C2 DE 3043446 C2 DE3043446 C2 DE 3043446C2 DE 3043446 A DE3043446 A DE 3043446A DE 3043446 A DE3043446 A DE 3043446A DE 3043446 C2 DE3043446 C2 DE 3043446C2
Authority
DE
Germany
Prior art keywords
solution
hydrochloride
virus
interferon
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3043446A
Other languages
German (de)
English (en)
Other versions
DE3043446A1 (de
Inventor
Yoshiyuki Saitama Jp Tahara
Hiroyasu Ageo Saitama Jp Koyama
Yasuhiro Niiza Saitama Jp Komatsu
Reiko Tokio/Tokyo Jp Kubota
Toshihiro Saitama Jp Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Publication of DE3043446A1 publication Critical patent/DE3043446A1/de
Application granted granted Critical
Publication of DE3043446C2 publication Critical patent/DE3043446C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19803043446 1979-11-19 1980-11-18 Decaprenylaminderivate Granted DE3043446A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14882179A JPS5673047A (en) 1979-11-19 1979-11-19 Decaprenylamine derivative

Publications (2)

Publication Number Publication Date
DE3043446A1 DE3043446A1 (de) 1981-08-27
DE3043446C2 true DE3043446C2 (no) 1989-01-05

Family

ID=15461466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803043446 Granted DE3043446A1 (de) 1979-11-19 1980-11-18 Decaprenylaminderivate

Country Status (4)

Country Link
JP (1) JPS5673047A (no)
DE (1) DE3043446A1 (no)
FR (1) FR2470111B1 (no)
GB (1) GB2065110B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57192342A (en) * 1981-05-18 1982-11-26 Nisshin Flour Milling Co Ltd Isoprenylamine derivative
JPS57192339A (en) * 1981-05-18 1982-11-26 Nisshin Flour Milling Co Ltd Isoprenylamine derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444202A (en) * 1966-05-12 1969-05-13 Shell Oil Co Production of n-(2,7,11(15)-alkapolyenyl)amines
US4139560A (en) * 1974-02-22 1979-02-13 Ciba Geigy Corporation Nonylamines

Also Published As

Publication number Publication date
FR2470111B1 (fr) 1985-07-19
DE3043446A1 (de) 1981-08-27
JPS6252739B2 (no) 1987-11-06
GB2065110A (en) 1981-06-24
JPS5673047A (en) 1981-06-17
FR2470111A1 (fr) 1981-05-29
GB2065110B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE3218792C2 (de) Isoprenylaminderivate und deren Säureadditionssalze, sowie diese enthaltende pharmazeutische Mittel
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE3043437C2 (no)
DE1949813A1 (de) Substituierte Pyrazole
DE3116211A1 (de) "nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel"
DE2406065C2 (de) Neue Isoindolin-1-on-Derivate, deren Säureadditionssalze ihre Herstellung und die Zusammensetzungen, die sie enthalten
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3043446C2 (no)
DE69424816T2 (de) N-Benzylpiperazinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Zusammensetzungen
DE3218822C2 (no)
DE3017026C2 (de) Isoprenylamine und ihre Säureadditionssalze sowie sie enthaltende Antivirus-Mittel für Wirbeltiere
DE3116250C2 (no)
DE1493083B1 (de) Linolsaeureamide und Verfahren zu ihrer Herstellung
DE3218743C2 (no)
DE3043498C2 (no)
CH630895A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
DE3116232A1 (de) Nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel
DE3218757C2 (no)
DE2610679C2 (de) Sulfinylgruppenhaltige Oximätherderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
EP0462150B1 (de) Neue aryloxy-alkylamine, deren herstellung und diese enthaltende arzneimittel
DE69507113T2 (de) Therapeutisches Mittel zur Behandlung von ischämischen oder Reperfusion Schädigungen des Myokards
AT329551B (de) Verfahren zur herstellung neuer derivate des n-phenyl-n-alkanoyl-2-aminoindans
DE2031360A1 (de) Neue cyclische Verbindungen und Ver fahren zu ihrer Herstellung
DE3020113A1 (de) 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee